Journals / Türkiye Parazitoloji Dergisi / 2012 / Cilt: 36 - Sayı: 2

Taurolidine use as a scolicidal agent: We need different methodologies

Taurolidinin skolisidal ajan olarak kullanımı: Farklı metodlara ihtiyacımız var

Pages
131–132
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

AYTAÇ, E., TEKSÖZ, S. (2022). Taurolidine use as a scolicidal agent: We need different methodologies. Türkiye Parazitoloji Dergisi, Cilt: 36 - Sayı: 2, 131–132. https://ajindex.com/articles/630416

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Ekçi B, Gürol Y, Aydin I, Yalniz F, Ozcan M, Zengin K. The protoskolicidal effect of 1% polyvinylpyrrolidone-iodine (PVP-1) and 2% taurolidine on abdominal hydatidosis. Turkiye Parazitol Derg 2010; 34: 152-5
  2. Karayalcin K, Aras N. Kist hidatik cerrahisinde skolisidal madde kullanımı. T Klin J Surgery 1998; 3: 216-8
  3. Eyupoglu B, Doganay M, Reis E, Yuksek YN, Kulacoglu S, Kama NI. The effects of scolocidal agents on hepatopancreaticobiliary system “An experimenal study”. Turk J Gastroenterol 1999; 10: 280-6
  4. Willatts SM, Radford S, Leitermann M. Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebocontrolled, double-blind trial. Crit Care Med 1995; 23: 1033-9. [CrossRef] 5) Gong L, Greenberg HE, Perhach JL, Waldman SA, Kraft WK. The Pharmacokinetics of Taurolidine Metabolites in Healthy Volunteers. Clin Pharmacol 2007; 47; 697-703. [CrossRef] 6) Browne MK, Pharmacological and clinical studies on Taurolin. In: Bruckner WL, Pfirrmann RW, eds. A New Concept in Antimicrobial Chemotherapy for Surgical Infection, Baltimore: Urban & Schwarzenberg, 1985. 51
  5. Browne MK. The treatment of peritonitis by an antiseptic—Taurolin. Pharmatherapeutica 1981; 2: 517-22
  6. Blenkharn JJ. Sustained anti-adherence activity of taurolidine (Taurolin) and noxythiolin (Noxyflex S) solutions. J Pharm Pharmacol 1988; 40: 509-11. [CrossRef] 9) Gorman SP, McCafferty DF, Woolfson AD, Jones DS. Electron and light microscope observations of bacterial cell surface effects due to taurolidine treatment. Lett Appl Microbiol 1987; 4: 103-9. [CrossRef] 10) Monson JR, Ramsey PS, Donohue JH. Taurolidine inhibits tumor necrosis factor (TNF) toxicity: new evidence of TNF and endotoxin synergy. Eur J Surg Oncol 1993; 3: 226-31
  7. Watson RW, Redmond HP, McCarthy J, Bouchier-Hayes D. Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by amino acid taurine. J Leukoc Biol 1995; 58: 299-306
  8. Leithauser ML, Rob PM, Sack K. Pentoxifylline, cyclosporine A and taurolidine inhibit endotoxin-stimulated tumor necrosis factoralpha production in rat mesangial cell cultures. Exp Nephrol 1997; 1: 100-4.